Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Army
Deloitte
Citi
McKesson
Fuji
Accenture
UBS
Merck

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,013,556

« Back to Dashboard

Summary for Patent: 5,013,556
Title: Liposomes with enhanced circulation time
Abstract:A liposome composition which contains between 1-20 mole percent of an amphipathic lipid derivatized with a polyalkylether, as exemplified by phosphatidylethanolamine derivatized with polyethyleneglycol. The derivatized lipid enchances the circulation time of the liposomes severalfold, and this enhancement is achieved with either fluid or membrane-rigidifying liposome components. Also disclosed are methods for delivering a drug for slow release from the bloodstream, and for targeting a selected tissue or cells with liposomes, via the bloodstream.
Inventor(s): Woodle; Martin C. (Menlo Park, CA), Martin; Francis J. (San Francisco, CA), Yau-Young; Annie (Los Altos, CA), Redemann; Carl T. (Walnut Creek, CA)
Assignee: Liposome Technology, Inc. (Menlo Park, CA)
Application Number:07/425,224
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Delivery; Compound; Use;

Drugs Protected by US Patent 5,013,556

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,013,556

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2146565 ➤ Try a Free Trial
Canada 2067178 ➤ Try a Free Trial
Canada 2067133 ➤ Try a Free Trial
Germany 19675048 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Queensland Health
Baxter
QuintilesIMS
Boehringer Ingelheim
Johnson and Johnson
Cerilliant
Deloitte
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.